IRCT2017030732933N1Completed未知
A comparison between efficacy and safety of 585-nanometer pulsed dye laser alone and with cryotherapy in treating superficial basal cell carcinoma
Ahvaz Jundishapur University of Medical Sciences0 sites32 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 32
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Pathologically documented basal cell carcinoma; maximum tumor diameter of 30 millimeters
- •Exclusion criteria: Skins with Fitzpatrick type of higher than 3; coagulation disorders or recent receiving of anti-coagulant agents; consumption of light-sensitive drugs
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 1
A trial comparing efficacy and safety of NN5401 withinsulin glargine, both in combination with oralantidiabetic drugs in subjects with type 2 diabetestype 2 diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-005767-34-FRovo Nordisk A/S
Active, not recruiting
Not Applicable
A trial comparing efficacy and safety of NN5401 with insulin glargine in insulin naive subjects with type 2 diabetesEUCTR2009-011271-78-ATovo Nordisk A/S752
Active, not recruiting
Not Applicable
A trial comparing efficacy and safety of NN5401 withinsulin glargine, both in combination with oralantidiabetic drugs in subjects with type 2 diabetestype 2 diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-005767-34-SEovo Nordisk A/S450
Active, not recruiting
Phase 1
A trial comparing efficacy and safety of NN5401 with insulin glargine in insulin naive subjects with type 2 diabetesEnsayo para comparar la eficacia y seguridad de NN5401 frente a insulina glargina en sujetos con Diabetes tipo 2 sin tratamiento previo con insulinaEUCTR2009-011271-78-ESovo Nordisk A/S
Active, not recruiting
Not Applicable
A trial comparing efficacy and safety of NN5401 withinsulin glargine, both in combination with oralantidiabetic drugs in subjects with type 2 diabetesEUCTR2008-005767-34-PLovo Nordisk A/S450